These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8111713)

  • 21. Treatment of gynecological adenocarcinomas with a combination of ifosfamide, adriamycin and cisplatin.
    Nishida T; Nagasue N
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 May; 40(5):635-9. PubMed ID: 3133435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancer.
    Ingle JN; Krook JE; Mailliard JA; Hartmann LC; Wieand HS
    Am J Clin Oncol; 1995 Dec; 18(6):498-501. PubMed ID: 8526193
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A combination of ifosfamide and mitoxantrone as salvage therapy in patients with advanced ovarian cancer.
    Nardi M; Della Giulia M; Pollera CF; Marolla P; Ruggeri EM; Iacovelli A; Atlante G; Calabresi F
    Cancer Chemother Pharmacol; 1996; 38(3):298-301. PubMed ID: 8646807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A phase II trial of paclitaxel in patients with advanced or recurrent adenocarcinoma of the endometrium: a Gynecologic Oncology Group study.
    Ball HG; Blessing JA; Lentz SS; Mutch DG
    Gynecol Oncol; 1996 Aug; 62(2):278-81. PubMed ID: 8751561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of ifosfamide combined with Mesna uroprotection in advanced non-small-cell lung carcinoma and other solid tumors.
    Nobile MT; Rosso R; Brema F; Cinquegrana A; Santi L
    Tumori; 1984 Oct; 70(5):433-7. PubMed ID: 6438851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Doxorubicin and ifosfamide-mesna in advanced and recurrent uterine sarcomas.
    Piura B; Rabinovich A
    Eur J Gynaecol Oncol; 2005; 26(3):275-8. PubMed ID: 15991525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclophosphamide or ifosfamide in patients with advanced and/or recurrent endometrial carcinoma: a randomized phase II study of the EORTC Gynecological Cancer Cooperative Group.
    Pawinski A; Tumolo S; Hoesel G; Cervantes A; van Oosterom AT; Boes GH; Pecorelli S
    Eur J Obstet Gynecol Reprod Biol; 1999 Oct; 86(2):179-83. PubMed ID: 10509788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral ifosfamide/mesna versus intravenous ifosfamide/mesna in non-small-cell lung cancer: a randomized phase II trial of the EORTC lung cancer cooperative group.
    Manegold C; Drings P; Pawinski A; Lentz MA; van Glabbeke M; van Zandwijk N; Bachmann P; Schnaars Y; Skacel Z; Zatloukal P; Dolensky J; Jackevicius A; Petruzelka L; Giaccone G
    Ann Oncol; 1996 Aug; 7(6):637-9. PubMed ID: 8879380
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
    Zanetta G; Fei F; Mangioni C
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study.
    Sutton G; Brunetto VL; Kilgore L; Soper JT; McGehee R; Olt G; Lentz SS; Sorosky J; Hsiu JG
    Gynecol Oncol; 2000 Nov; 79(2):147-53. PubMed ID: 11063636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group study.
    Sutton G; Blessing JA; Malfetano JH
    Gynecol Oncol; 1996 Aug; 62(2):226-9. PubMed ID: 8751554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ifosfamide with mesna in squamous carcinoma of the cervix: phase II results in patients with advanced or recurrent disease.
    Hannigan EV; Dinh TV; Doherty MG
    Gynecol Oncol; 1991 Nov; 43(2):123-8. PubMed ID: 1743553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ifosfamide and mesna for the treatment of advanced squamous cell head and neck cancer. A GETLAC study.
    Cervellino JC; Araujo CE; Pirisi C; Francia A; Cerruti R
    Oncology; 1991; 48(2):89-92. PubMed ID: 1900124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase I study of prolonged ambulatory infusion of Ifosfamide with oral mesna.
    Olver I; Keefe D; Myers M; Caruso D
    Chemotherapy; 2005 May; 51(2-3):142-6. PubMed ID: 15886474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II trial of ifosfamide and cisplatin in the treatment of metastatic sarcomas: a Southwest Oncology Group study.
    Budd GT; Metch B; Weiss SA; Weick JK; Fabian C; Stephens RL; Balcerzak SP
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S213-6. PubMed ID: 8453701
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II trial of ifosfamide in the treatment of metastatic hormone-refractory patients with prostatic cancer.
    Mahjoubi M; Azab M; Ghosn M; Theodore C; Droz JP
    Cancer Invest; 1990; 8(5):477-81. PubMed ID: 2124944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.
    Shirinian M; Lee JS; Dhingra HH; Greenberg J; Hong WK
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):49-53. PubMed ID: 1329212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemotherapy with high dose ifosfamide/mesna plus cisplatin for the treatment of ovarian cancer: a study of the Grupo de Estudio y Tratamiento Latino-Americano del Cancer.
    Araujo CE; Cervellino JC; Pirisi C; Pannunzio O; Callegari J
    J Surg Oncol; 1991 Mar; 46(3):198-202. PubMed ID: 1901372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease.
    Markman M; Hakes T; Reichman B; Lewis JL; Rubin S; Jones W; Almadrones L; Pizzuto F; Hoskins W
    J Clin Oncol; 1992 Feb; 10(2):243-8. PubMed ID: 1732425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclophosphamide versus ifosfamide: preliminary report of a randomized phase II trial in adult soft tissue sarcomas.
    Bramwell VH; Mouridsen HT; Santoro A; Blackledge G; Somers R; Thomas D; Sylvester R; Van Oosterom A
    Cancer Chemother Pharmacol; 1986; 18 Suppl 2():S13-6. PubMed ID: 3102089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.